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Abstract
Background:  Bleeding from small bowel neoplasms account for 1–4% of cases of upper
gastrointestinal haemorrhage. Renal cell carcinoma constitutes 3% of all adult malignancies and
often presents insidiously. Consequently 25–30% of patients have metastases at the time of
diagnosis. Gastrointestinal bleeding from renal cell carcinoma metastases is an uncommon and
under-recognised manifestation of this disease.
Case Report: In this report we describe two cases of gastrointestinal bleeding from renal cell
carcinoma metastases – in one patient bleeding heralded the primary manifestation of disease and
in the other signified recurrence of disease following nephrectomy.
Conclusion: These cases highlight the importance endoscopic vigilance in cases of undiagnosed
upper gastrointestinal haemorrhage, especially in patients with a past history of renal cell
carcinoma.
Background
It is estimated that in 7–25% of patients who undergo
endoscopy for suspected upper gastrointestinal haemor-
rhage, no source of bleeding is identified [1]. Malignant
causes of upper gastrointestinal bleeding account for 1–
4% of cases. Tumours of the small intestine are uncom-
mon, comprising 0.35% of all malignancies [1], and
symptoms are frequently non-specific. Consequently
diagnosis is often difficult and may be delayed. Indeed,
less than 50% of small bowel lesions are considered sur-
gically resectable at diagnosis [2]. Thorough endoscopic
evaluation of the upper small intestine and a high index
of suspicion are vital for correct diagnosis and appropriate
management of these lesions.
Renal cell carcinoma (RCC) behaves unpredictably and
has a diverse range of clinical manifestations. Patients
often present insidiously with vague abdominal symp-
toms – the classic triad of haematuria, loin pain and
abdominal mass is found in only 4–17% [3,4]. Accord-
ingly, 25–30% of patients are found to have metastases at
diagnosis. A further 30–50% of patients with local disease
will develop metastases during the course of their illness
[5].
Metastases to the pancreas and small intestine in RCC are
rare, but can present as gastrointestinal bleeding [6,7]. We
describe two cases of pancreatico-duodenal metastasis in
RCC presenting with upper gastrointestinal haemorrhage
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– in one case bleeding was the first manifestation of dis-
ease, and in the other bleeding heralded disease recur-
rence.
Case presentation
Case 1
A 67 year-old male with a past history of angina and
arthritis presented with a one week history of melaena
and lethargy. He was found to be anaemic (Hb 6.7 g/dl,
MCV 92.2 fl). Endoscopy revealed moderate haemor-
rhagic gastritis and a Campylobacter-like organism (CLO)
-positive duodenal ulcer, but no signs of recent bleeding.
His non-steroidal anti-inflammatory medication was
stopped and eradication therapy prescribed. He remained
an in-patient for one week, during which time seven units
of blood were transfused to correct his Hb to 11.6 g/dl.
Six weeks later he presented with abdominal pain and fur-
ther melaena requiring a 2-unit blood transfusion. Endos-
copy revealed mild antral gastritis and a normal
duodenum but no source of bleeding. Colonoscopy was
normal. Two weeks later endoscopy was repeated which
showed a small amount of fresh blood in the duodenal
bulb, but no obvious lesion was seen to account for the
bleeding.
Three weeks later, he remained symptomatically anaemic,
requiring further blood transfusion. Because of the history
of melaena he underwent a fourth endoscopy which
revealed a small, highly vascular polyp in the duodenum
just beyond the angulus which bled easily on contact.
Multiple biopsies were taken. The endoscopist was con-
cerned about the possibility of a pancreatic neoplasm
eroding into the duodenum and therefore an abdominal
CT was arranged. Surprisingly, this demonstrated a large
left renal mass with evidence of left adrenal and lung
metastases, and a polypoidal mass in the medial wall of
the second part of the duodenum arising from the pan-
creas (Figure 1). Histology from the duodenal polyp
showed small, vacuolated, clear cells highlighted by
immunostaining with CAM 5.2 and showing strong reac-
tivity with Vimentin. These findings confirmed the diag-
nosis of metastatic RCC.
Over the three month period from initial presentation to
diagnosis he required transfusion of a total of twenty units
of blood for recurrent symptomatic anaemia. Given the
history of recurrent melaena, coeliac angiography was
undertaken with a view to trans-catheter embolisation.
This was performed successfully via occlusion of the ante-
rior and posterior pancreaticoduodenal vessels using coils
(Figure 2A and 2B).
He subsequently underwent palliative left nephrectomy
and histology from the resected specimen confirmed a
grade 2 clear cell variant of RCC. He completed a course
of interferon therapy and was able to lead a normal life for
approximately 18 months, with no recurrence of anaemic
symptoms or melaena. He subsequently developed pain-
ful maxillary metastases for which he received a course of
Coeliac angiogram Figure 2
Coeliac angiogram. Figure 2A is an angiogram of the coe-
liac trunk. This demonstrates a highly vascular mass around 
the duodenum and pancreas and its blood supply from the 
pancreaticoduodenal arteries. Numerous other small vascu-
lar blushes are seen which represent further pancreatic 
metastases. Figure 2B is taken post- embolisation and dem-
onstrates successful occlusion of the tumour's blood supply.
Abdominal CT scan Figure 1
Abdominal CT scan. Abdominal CT scan demonstrating a 
left-sided renal tumour (thick arrow) and a polypoidal mass 
in the wall of the second part of the duodenum (thin arrow) 
arising from the pancreas (not shown).BMC Gastroenterology 2007, 7:4 http://www.biomedcentral.com/1471-230X/7/4
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radiotherapy, but died at home nearly two years after his
initial presentation.
Case 2
A 75 year old male with a past history of left nephrectomy
9 years previously for RCC was referred for out-patient
investigation of iron-deficiency anaemia (Hb 10.3, MCV
78.9). Gastroscopy revealed a CLO-negative duodenal
ulcer. Duodenal biopsies were within normal histological
limits. Proton-pump inhibitor and iron therapy was pre-
scribed and the patient was scheduled for review in the
out-patient department.
He remained anaemic three months later and repeat gas-
troscopy and a colonoscopy were arranged. Colonoscopy
was normal, but gastroscopy revealed a fleshy vascular
polyp in the duodenal bulb which was biopsied. A CT
scan of the chest and abdomen, and a bone scan revealed
a pancreatic mass invading the duodenum (Figure 3) but
no metastatic disease elsewhere. Histology from the polyp
showed multiple large clear cells which stained positively
for MNF116 and Vimentin, confirming the diagnosis of
metastatic RCC.
The patient was unable to tolerate interferon therapy. He
became jaundiced due to tumour invasion of the distal
common bile duct which was managed successfully by
endoscopic biliary stenting. He received a total of 13-units
of blood for symptomatic anaemia around the time met-
astatic disease was diagnosed, but since being commenced
on a proton pump inhibitor his haemoglobin has
remained stable.
Discussion
RCC accounts for 3% of adult malignancies. It arises from
the proximal tubular epithelium of the kidney and has
male preponderance (M:F 2:1). Mean age at presentation
is 50–70 years. Both sporadic and hereditary forms exist
which are associated with genetic abnormalities on the
short arm of chromosome 3 (3p). In the United Kingdom
the incidence has increased by 22% over 10 years while in
the United States there has been an increase of 50% in 30
years [8]. Deaths worldwide from kidney cancer exceed
100,000 per year [9].
Multiple risk factors include increased age, smoking, obes-
ity, long-term dialysis, exposure to asbestos, petroleum
products and cadmium, and several genetic syndromes
including familial clear cell carcinoma, von Hippel-
Lindau syndrome, and tuberous sclerosis [8].
Spread in RCC is lymphatic, haematogenous, transcoe-
lomic, or by direct invasion. The most common sites of
metastasis in RCC are the lung (75%) and lymph nodes
(36%) followed by the bones (20%) and liver (18%) [9].
Pancreatic metastasis is estimated at 1.3–1.9% of autopsy
series; only 50% of pancreatic metastases are sympto-
matic, by 1996 only 66 cases of pancreatic metastasis in
RCC had been reported [10,11]. Solitary metastasis in
RCC occurs in less than 5% of patients [9].
Autopsy series suggest only 2% of all tumours metastasise
to the small intestine – RCC make up 7.1% of these
lesions [12]. A series published by Graham [13] stated
only 4% of RCC metastasize to the small intestine, while
a more recent Mayo Clinic 50-year review found only 3
cases of small intestinal metastasis in RCC, which did not
include cases of direct tumour extension [14].
Of all intestinal segments involved RCC metastasis to the
duodenum occurs least frequently [15]. The overwhelm-
ing majority of tumours metastasising to the duodenum
arise from the right kidney given its anatomic proximity
[16], and of the few published reports most commonly
involve the periampullary region, followed by the duode-
nal bulb. These usually manifest as gastrointestinal bleed-
ing, although cases of small bowel intussusception are
described [16-19]. Direct invasion of the duodenum from
pancreatic metastases is also reported [13,20-22].
Gastrointestinal bleeding as the presenting symptom of a
primary renal cell carcinoma is described rarely in the lit-
erature [23,24]. Bleeding is more commonly encountered
in patients already known to have metastatic disease, or as
the first symptom of metastatic disease in patients who
have previously undergone nephrectomy for RCC
[7,25,26].
Abdominal CT scan Figure 3
Abdominal CT scan. CT scan demonstrating the presence 
of a mass in the area of the pancreatic head and protruding 
into the duodenum (thick arrow) – note the previous left 
nephrectomy (thin arrow).BMC Gastroenterology 2007, 7:4 http://www.biomedcentral.com/1471-230X/7/4
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Here we present a rare case of RCC whose primary mani-
festation of disease was with symptoms of upper gastroin-
testinal bleeding related to pancreatic metastases invading
the duodenum. The source of bleeding in this case was
obscure and initially missed by conventional gastroscopy
– earlier diagnosis may have been facilitated using a side-
viewing endoscope as described previously in a case of
RCC metastasizing to the duodenal ampulla [27]. Bleed-
ing in our patient was managed radiologically and with-
out complication, by selective trans-catheter embolisation
of the anterior and posterior pancreaticoduodenal arter-
ies. Arterial embolisation to control bleeding from duode-
nal metastasis from RCC has been previously reported to
be successful [28,29].
We also outline a case presenting 9 years after nephrec-
tomy for RCC with isolated pancreatic and duodenal
metastases causing intestinal bleeding. This is unusual as
a recent study suggests the majority (83%) of tumours
recur within 2 years of curative surgery, with higher recur-
rence rates in tumours of increasing size [30]. However,
cases of late recurrence presenting as GI bleeding have
been reported at 19 years after nephrectomy for RCC [31].
The longest documented survival from nephrectomy to
the diagnosis of pancreatic metastasis is 27 years, and a
more prolonged interval from nephrectomy to diagnosis
seems to confer a better prognosis [10], presumably as a
result of less aggressive tumour biology. Interestingly, in
both patients described in our paper, RCC originated in
the left kidney.
Palliative nephrectomy may alleviate local symptoms and
can be undertaken in selected cases, but should be
weighed against the burden of surgical morbidity and
mortality, and is not justifiable for inducing disease
regression which occurs in < 1% of patients [32]. Out-
come in metastatic RCC is generally poor, with 48% 1-
year and 9% 5-year survival rates. Although evidence for
the role of metastasectomy in RCC is lacking [25], surgery
(by duodenopancreatectomy or total pancreatectomy)
should be strongly considered in especially patients with
isolated pancreatic metastases where it may provide 5-
year survival rates of 31–68% [33,34].
Conclusion
Gastrointestinal bleeding from intestinal metastasis may
present with overt haematemesis or signs of occult blood
loss. Due to its rarity, small intestinal metastasis is often
not suspected as a cause of gastrointestinal bleeding. In
this report, we hope to alert clinicians to the possibility of
intestinal metastasis, or local small bowel invasion from
pancreatic metastasis, as a cause for gastrointestinal bleed-
ing in patients with a past history of RCC, regardless of the
time since nephrectomy. We present a rare case of RCC
whose primary manifestation was with gastrointestinal
bleeding. We highlight the importance of endoscopic vig-
ilance in correctly diagnosing the source of bleeding from
the upper gastrointestinal tract, and demonstrate the
effective use of selective angiographic embolisation in
controlling intestinal bleeding from metastatic RCC.
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